Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limitedverified

SBMFF

Price:

$0.633

Market Cap:

$70.72B

Sino Biopharmaceutical Limited operates as a leading investment holding entity and a research and development-focused pharmaceutical conglomerate, primarily active within the People's Republic of China. Its business activities are organized into three primary divisions: Modernised Chinese Medicines and Chemical Medicines, Investment initiatives, and other miscellaneous operations. The company offers a comprehensive range of pharmaceutical products spanning various therapeutic areas. This portfolio includes oncology medications like Qingkeshu, Anxian, Yinishu, Genike, Anyue capsules, and Leweixin injections; cardio-cerebral vascular drugs such as Kaina and Anrixin tablets; and treatments for ...[Read more]

Industry

Biotechnology

IPO Date

2010-02-22

Stock Exchange

OTC

Ticker

SBMFF

The Enterprise Value as of June 2026 (TTM) for Sino Biopharmaceutical Limited (SBMFF) is 79.40B

According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 79.40B. This represents a change of 31.04% compared to the average of 60.59B of the last 4 quarters.

Sino Biopharmaceutical Limited (SBMFF) Historical Enterprise Value (quarterly & annually)

How has SBMFF Enterprise Value performed in the past?

The mean historical Enterprise Value of Sino Biopharmaceutical Limited over the last ten years is 81.83B. The current 79.40B Enterprise Value has changed 9.60% with respect to the historical average. Over the past ten years (40 quarters), SBMFF's Enterprise Value was at its highest in in the June 2020 quarter at 165.23B. The Enterprise Value was at its lowest in in the September 2025 quarter at 0.

Quarterly (TTM)
Annual

Average

81.83B

Median

82.41B

Minimum

35.82B

Maximum

123.00B

Sino Biopharmaceutical Limited (SBMFF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sino Biopharmaceutical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 135.49%

Maximum Annual Enterprise Value = 123.00B

Minimum Annual Increase = -36.96%

Minimum Annual Enterprise Value = 35.82B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025108.90B107.97%
202452.37B-29.36%
202374.13B-7.88%
202280.47B-6.40%
202185.98B-30.10%
2020123.00B2.37%
2019120.15B125.95%
201853.17B-36.96%
201784.35B135.49%
201635.82B-17.00%

Sino Biopharmaceutical Limited (SBMFF) Average Enterprise Value

How has SBMFF Enterprise Value performed in the past?

The current Enterprise Value of Sino Biopharmaceutical Limited (SBMFF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

78.47B

5-year avg

80.37B

10-year avg

81.83B

Sino Biopharmaceutical Limited (SBMFF) Enterprise Value vs. Peers

How is SBMFF’s Enterprise Value compared to its peers?

Sino Biopharmaceutical Limited’s Enterprise Value is greater than Silo Pharma, Inc. (1.44M), greater than Inventiva S.A. (394.42M), greater than BioCardia, Inc. (4.68M), greater than UroGen Pharma Ltd. (1.69B), greater than SB Technology Holdings, Inc. (421.91K), greater than Kaleido Biosciences, Inc. (-16775738.00), greater than Regen BioPharma, Inc. (970.96K), greater than Dominari Holdings Inc. (28.34M), greater than GT Biopharma, Inc. (-3999773.00), greater than Fortress Biotech, Inc. (-98072210.00), greater than Innovation Pharmaceuticals Inc. (-637496.00), greater than Karuna Therapeutics, Inc. (12.43B), greater than Akari Therapeutics, Plc (12.50M), greater than Salarius Pharmaceuticals, Inc. (-4756472.00), greater than Axcella Health Inc. (-2482600.00), greater than Magenta Therapeutics, Inc. (-583861976.00), greater than Histogen Inc. (-7392565.00), greater than Can-Fite BioPharma Ltd. (7.57B), greater than BiondVax Pharmaceuticals Ltd. (22.03M), greater than Oramed Pharmaceuticals Inc. (143.49M), greater than MediWound Ltd. (117.84M), greater than BioLineRx Ltd. (19.92M),

Build a custom stock screener for Sino Biopharmaceutical Limited (SBMFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sino Biopharmaceutical Limited (SBMFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Sino Biopharmaceutical Limited's Enterprise Value?

What is the highest Enterprise Value for Sino Biopharmaceutical Limited (SBMFF)?

What is the 3-year average Enterprise Value for Sino Biopharmaceutical Limited (SBMFF)?

What is the 5-year average Enterprise Value for Sino Biopharmaceutical Limited (SBMFF)?

How does the current Enterprise Value for Sino Biopharmaceutical Limited (SBMFF) compare to its historical average?